// App-Quantinova.ai

: Repeat Measurements of Complement proteins C3a and C5a in COPD patients

Researchers

Presenter

  • Thomas Southworth

Principal Investigators

  • Caroline Pattwell

  • Helen Richardson

  • Pascal Deschatelets

  • Cedric Francois

  • Federico Gross

  • Delphine El Mehdi

  • Carolina Vega

  • Lisa Tan

  • Dave Singh

Medical Centers

  • The University of Manchester, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom

  • Medicines Evaluation Unit, Manchester, United Kingdom.

  • Paramstat Ltd, Sandwich, United Kingdom

  • Apellis Pharmaceuticals Inc, Crestwood, KY, United States of America

  • Lisa Tan Pharma Consulting, Cambridge, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Complement 3

  • Complement Component 5a

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A